Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy of Traditional Chinese Medicine on Ameliorating IVF-ET Outcomes of Diminished Ovarian Reserve Patients

Phase 3

Not yet recruiting

Conditions: Infertility, Female
Diminished Ovarian Reserve

Interventions: Drug: Medical prescription before ovulation
Drug: Medical prescription after ovulation

First Posted Date: 2022-10-13

Last Posted Date: 2022-10-27

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 266

Registration Number: NCT05577455

Etomidate Induction in Hysteroscopic Surgery

Not Applicable

Conditions: Etomidate Induced Dose
Hysteroscopic Surgery

Interventions: Drug: etomidate
Drug: propofol

First Posted Date: 2022-08-30

Last Posted Date: 2022-08-30

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 200

Registration Number: NCT05520645

The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI

Phase 4

Not yet recruiting

Conditions: ST-segment Elevation Myocardial Infarction (STEMI)

Interventions: Drug: Ketotifen Fumarate
Drug: standard treatment

First Posted Date: 2022-08-23

Last Posted Date: 2022-08-23

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 60

Registration Number: NCT05511831

Reducing Postpartum Hemorrhage After Vaginal Delivery

Not Applicable

Not yet recruiting

Conditions: Vaginal Delivery
Postpartum Hemorrhage

Interventions: Other: Integrated Improvement strategies

First Posted Date: 2022-08-15

Last Posted Date: 2022-08-15

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 50

Registration Number: NCT05501106

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Application of 3D Printing Guide Plate in Spinal Minimally Invasive and Interventional Surgeries

Not Applicable

Not yet recruiting

Conditions: Ischemic Pain of the Lower Extremity
Radicular Pain
Low Back Pain
Lumbar Disc Herniation
Lumbar Spinal Stenosis
Radiculopathy
3D Printing Guide Plate
Lumbosacral Facet Joint Syndrome
Spinal Minimally Invasive and Interventional Surgeries

Interventions: Other: 3D printing guide plate
Other: Conventional guidance

First Posted Date: 2022-08-04

Last Posted Date: 2022-11-01

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 120

Registration Number: NCT05487690

Locations: 🇨🇳
Pain medicine center of Peking University Third Hospital, Beijing, Beijing, China

Degenerative Lumbar Scoliosis

Conditions: Degenerative Scoliosis
Scoliosis Lumbar Region

First Posted Date: 2022-08-03

Last Posted Date: 2022-12-01

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 640

Registration Number: NCT05485636

Locations: 🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China
🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

and more 5 locations

Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)

Not Applicable

Recruiting

Conditions: Premature Ovarian Insufficiency
Diminished Ovarian Reserve

Interventions: Other: Placebo
Dietary Supplement: NMN intervention

First Posted Date: 2022-08-03

Last Posted Date: 2022-10-12

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 200

Registration Number: NCT05485610

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Not yet recruiting

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: Anlotinib Hydrochloride
Drug: penpulimab
Radiation: SBRT

First Posted Date: 2022-08-03

Last Posted Date: 2022-08-03

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 32

Registration Number: NCT05485350

Zanubrutinib in the Treatment of Recurrent Refractory Mantle Cell Lymphoma

Recruiting

Conditions: Mantle Cell Lymphoma

First Posted Date: 2022-08-03

Last Posted Date: 2022-08-03

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 30

Registration Number: NCT05486013

Locations: 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China

Immediate Versus Postponed Freeze-all Embryo Transfer in Hyperresponders

Not Applicable

Completed

Conditions: IVF

Interventions: Biological: the timing of embryo transfer in freeze-all cycles

First Posted Date: 2022-08-02

Last Posted Date: 2024-11-27

Lead Sponsor: Peking University Third Hospital

Target Recruit Count: 845

Registration Number: NCT05483270

Locations: 🇨🇳
Peking university third hospital, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy